Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Vertex Pharmaceuticals Inc. Stock Rises 5.6%, Outperforms Peers

Vertex Pharmaceuticals Inc. Stock Rises 5.6%, Outperforms Peers

Dow JonesDow Jones2026/08/10 20:34

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Vertex Pharmaceuticals Inc. rose 5.6% to $523.91 on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.1% to 7,753.11 and Dow Jones Industrial Average falling 0.1% to 53,975.98.

This was the stock's second consecutive day of gains.

Vertex Pharmaceuticals Inc. closed 1.8% below its 52-week high of $533.67, which the company achieved on July 7th.

The stock outperformed some of its peers, as AbbVie Inc. rose 0.8% to $247.97, Krystal Biotech Inc. rose 1.6% to $331.59, and Arcturus Therapeutics Holdings Inc. fell 4.86% to $7.05.

Trading volume totaled 2.7 million, compared to the 50-day average of 1.6 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 10, 2026 16:34 ET (20:34 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!